Full Answer
Oral thrush. vaginal B37.3. ICD-10-CM Diagnosis Code B37.3. Candidiasis of vulva and vagina. 2016 2017 2018 2019 2020 Billable/Specific Code. Applicable To.
2018/2019 ICD-10-CM Diagnosis Code B20. Human immunodeficiency virus [HIV] disease. 2016 2017 2018 2019 Billable/Specific Code. B20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Candidiasis, unspecified. B37.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM B37.9 became effective on October 1, 2019. This is the American ICD-10-CM version of B37.9 - other international versions of ICD-10 B37.9 may differ.
Oral mucositis (ulcerative) due to antineoplastic therapy 2016 2017 2018 2019 2020 2021 Billable/Specific Code K12.31 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM K12.31 became effective on October 1, 2020.
ICD-10-CM Code for Human immunodeficiency virus [HIV] disease B20.
B37. 0 - Candidal stomatitis | ICD-10-CM.
Following ICD-10 guidelines, if a patient has or has had an HIV related condition, use B20 AIDS. If the patient has a positive HIV status, without symptoms or related conditions, use Z21.
ICD-10 Coding: Diagnosis of B20 (HIV)
B37. 9 - Candidiasis, unspecified | ICD-10-CM.
9: Candidiasis, unspecified.
Code Z21 is used for patients who are asymptomatic, meaning they are HIV positive but have never had an HIV-related condition. Once that patient experiences an HIV-related condition, the Z21 code is no longer appropriate.
The code description for B20 is human immunodeficiency virus disease, therefore HIV disease is included in B20, according to the Official Guidelines for Coding and Reporting. That excludes note is specifically referring to a patient that has an asymptomatic HIV infection status, also known as HIV positive.
Z71. 7 — Human immunodeficiency virus [HIV] counseling.
Patients with aids are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (cmv) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-hodgkin's lymphoma and kaposi's sarcoma).
One or more indicator diseases, depending on laboratory evidence of hiv infection (cdc); late phase of hiv infection characterized by marked suppression of immune function resulting in opportunistic infections, neoplasms, and other systemic symptoms (niaid). rheumatoid arthritis ( M05.-)
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (hiv), a cd4-positive t-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms.